1	British	british	JJ	_	2	amod	_
2	drugs	drug	NNS	_	3	nsubj	_
3	giant	giant	JJ	p2=NN	4	amod	_
4	AstraZeneca	astrazeneca	NNP	_	5	nsubj	5:A0=PAG;21:A0
5	rejected	reject	VBD	p2=VBN|pb=reject.01	0	root	_
6	on	on	IN	_	5	prep	5:AM-TMP
7	Monday	monday	NNP	_	6	pobj	_
8	a	a	DT	_	11	det	_
9	final	final	JJ	_	11	amod	_
10	takeover	takeover	NN	_	11	nn	_
11	bid	bid	NN	p2=VBN	5	dobj	5:A1=PPT
12	from	from	IN	_	11	prep	_
13	US	us	NNP	_	14	nn	_
14	rival	rival	NN	p2=JJ	12	pobj	_
15	Pfizer	pfizer	NNP	_	16	nn	_
16	worth	worth	JJ	p2=VBD	11	amod	_
17	$	$	$	_	19	quantmod	_
18	117	0	CD	_	19	number	_
19	billion	#crd#	CD	_	16	npadvmod	_
20	,	,	,	_	5	punct	_
21	saying	say	VBG	pb=say.01	5	advcl	5:AM-PRD
22	it	it	PRP	_	23	nsubj	23:A0=PAG;27:A0=PAG
23	undervalued	undervalue	VBD	pb=undervalue.01	21	ccomp	21:A1=PPT
24	the	the	DT	_	25	det	_
25	firm	firm	NN	p2=JJ	23	dobj	23:A1=PPT
26	and	and	CC	_	23	cc	_
27	created	create	VBD	p2=VBN|pb=create.01	23	conj	_
28	uncertainty	uncertainty	NN	_	27	dobj	27:A1=PPT
29	and	and	CC	_	28	cc	_
30	risk	risk	NN	p2=VB	28	conj	_
31	for	for	IN	_	28	prep	_
32	shareholders	shareholder	NNS	_	31	pobj	_
33	.	.	.	_	5	punct	_

1	Shares	share	NNS	_	4	nsubj	4:A1=PPT
2	in	in	IN	_	1	prep	_
3	AstraZeneca	astrazeneca	NNP	_	2	pobj	_
4	plunged	plunge	VBD	p2=VBN|pb=plunge.01	0	root	_
5	by	by	IN	_	4	prep	4:AM-MNR
6	about	about	RB	_	7	advmod	_
7	14.0	0	CD	_	8	num	_
8	percent	percent	NN	_	5	pobj	_
9	in	in	IN	_	4	prep	4:AM-LOC
10	early	early	JJ	_	11	amod	_
11	trading	trading	NN	_	9	pobj	_
12	.	.	.	_	4	punct	_

1	Pfizer	pfizer	NNP	p2=NN	3	nsubj	3:A0=PAG
2	had	have	VBD	_	3	aux	_
3	made	make	VBN	pb=make.02	19	ccomp	_
4	an	an	DT	_	8	det	_
5	improved	improved	JJ	_	8	amod	_
6	and	and	CC	_	5	cc	_
7	final	final	JJ	_	5	conj	_
8	offer	offer	NN	p2=VBP	9	nsubj	_
9	worth	worth	JJ	p2=$	3	ccomp	3:A1=PRD
10	85	0	CD	_	11	number	_
11	billion	#crd#	CD	_	12	num	_
12	euros	euro	NNS	_	9	npadvmod	_
13	or	or	CC	_	12	cc	_
14	£69	£0	CD	p2=$	15	number	_
15	billion	#crd#	CD	_	12	conj	_
16	on	on	IN	_	3	prep	_
17	Sunday	sunday	NNP	_	16	pobj	_
18	,	,	,	_	19	punct	_
19	pitched	pitch	VBD	p2=VBN|pb=pitch.04	0	root	_
20	at	at	IN	_	19	prep	19:AM-LOC
21	£55	£0	CD	p2=NN	20	pobj	_
22	per	per	IN	p2=FW	21	prep	_
23	share	share	NN	_	22	pobj	_
24	,	,	,	_	19	punct	_
25	but	but	CC	_	19	cc	_
26	said	say	VBD	pb=say.01	19	conj	_
27	it	it	PRP	_	30	nsubj	30:A0=PAG
28	would	would	MD	_	30	aux	30:AM-MOD
29	not	not	RB	_	30	neg	30:AM-NEG
30	proceed	proceed	VB	pb=proceed.01	26	ccomp	26:A1=PPT
31	without	without	IN	_	30	prep	30:AM-MNR
32	a	a	DT	_	33	det	_
33	recommendation	recommendation	NN	_	31	pobj	_
34	.	.	.	_	19	punct	_

1	The	the	DT	_	2	det	_
2	battle	battle	NN	_	3	nsubj	3:A1=PPT
3	is	be	VBZ	pb=be.01	0	root	_
4	the	the	DT	_	5	det	_
5	latest	late	JJS	_	3	attr	3:A2=PRD
6	in	in	IN	_	5	prep	_
7	a	a	DT	_	8	det	_
8	series	series	NN	_	6	pobj	_
9	of	of	IN	_	8	prep	_
10	recent	recent	JJ	_	12	amod	_
11	huge	huge	JJ	_	12	amod	_
12	moves	move	NNS	_	9	pobj	_
13	by	by	IN	_	12	prep	_
14	companies	company	NNS	_	13	pobj	_
15	in	in	IN	_	14	prep	_
16	the	the	DT	_	21	det	_
17	pharmaceutical	pharmaceutical	NN	p2=JJ	21	nn	_
18	and	and	CC	_	17	cc	_
19	health	health	NN	_	20	nn	_
20	care	care	NN	_	17	conj	_
21	sectors	sector	NNS	_	15	pobj	_
22	to	to	TO	_	23	aux	_
23	create	create	VB	pb=create.01	12	infmod	_
24	world	world	NN	_	26	hmod	_
25	-	-	HYPH	_	26	hyph	_
26	scale	scale	NN	p2=VB	27	nn	_
27	alliances	alliance	NNS	_	23	dobj	23:A1=PPT
28	.	.	.	_	3	punct	_

1	The	the	DT	_	3	det	_
2	Pfizer	pfizer	NNP	_	3	nn	_
3	bid	bid	NN	_	5	nsubj	5:A0
4	has	have	VBZ	_	5	aux	_
5	taken	take	VBN	pb=take.01	0	root	_
6	on	on	RP	p2=IN	5	prt	5:C-V
7	strong	strong	JJ	_	9	amod	_
8	political	political	JJ	_	9	amod	_
9	overtones	overtone	NNS	p2=NN	5	dobj	5:A1=PPT
10	in	in	IN	_	5	prep	5:AM-LOC
11	Britain	britain	NNP	_	10	pobj	14:AM-LOC
12	where	where	WRB	_	14	advmod	14:R-AM-LOC
13	there	there	EX	_	14	expl	_
14	is	be	VBZ	pb=be.02	11	rcmod	_
15	concern	concern	NN	_	14	attr	14:A1=PPT
16	that	that	IN	p2=WDT	25	complm	_
17	the	the	DT	_	18	det	_
18	centre	centre	NN	_	25	nsubj	25:A1=PPT
19	of	of	IN	_	18	prep	_
20	strategic	strategic	JJ	_	23	amod	_
21	decision	decision	NN	_	23	hmod	_
22	-	-	HYPH	p2=,	23	hyph	_
23	making	making	NN	p2=VBG	19	pobj	_
24	might	might	MD	_	25	aux	25:AM-MOD
25	move	move	VB	pb=move.01	15	ccomp	_
26	abroad	abroad	RB	_	25	advmod	25:AM-DIR
27	,	,	,	_	25	punct	_
28	that	that	IN	p2=DT	32	complm	_
29	jobs	job	NNS	_	32	nsubjpass	32:A1=PPT
30	might	might	MD	_	32	aux	32:AM-MOD
31	be	be	VB	_	32	auxpass	_
32	cut	cut	VBN	pb=cut.02	25	advcl	_
33	and	and	CC	_	32	cc	_
34	research	research	NN	p2=VB	38	nsubj	38:A1=PPT
35	in	in	IN	_	34	prep	_
36	Britain	britain	NNP	_	35	pobj	_
37	eventually	eventually	RB	_	38	advmod	38:AM-TMP
38	scaled	scale	VBD	p2=VBN|pb=scale.01	32	conj	_
39	back	back	RP	p2=RB	38	prt	38:A5=VSP
40	.	.	.	_	5	punct	_

1	"	"	``	_	48	punct	_
2	We	we	PRP	_	4	nsubj	4:A0=PAG
3	have	have	VBP	_	4	aux	_
4	rejected	reject	VBN	pb=reject.01	48	ccomp	48:A1=PPT
5	Pfizer	pfizer	NNP	_	8	poss	_
6	's	's	POS	_	5	possessive	_
7	final	final	JJ	_	8	amod	_
8	proposal	proposal	NN	_	4	dobj	4:A1=PPT
9	because	because	IN	_	11	mark	_
10	it	it	PRP	_	11	nsubj	15:A0=PAG;11:A1=PPT
11	is	be	VBZ	pb=be.01	4	advcl	4:AM-CAU
12	inadequate	inadequate	JJ	_	11	acomp	11:A2=PRD
13	and	and	CC	_	11	cc	_
14	would	would	MD	_	15	aux	15:AM-MOD
15	present	present	VB	p2=JJ|pb=present.01	11	conj	_
16	significant	significant	JJ	_	17	amod	_
17	risks	risk	NNS	_	15	dobj	15:A1=PPT
18	for	for	IN	_	17	prep	_
19	shareholders	shareholder	NNS	_	18	pobj	_
20	,	,	,	_	15	punct	_
21	while	while	IN	_	23	mark	_
22	also	also	RB	_	23	advmod	_
23	having	have	VBG	pb=have.03	15	advcl	_
24	serious	serious	JJ	_	25	amod	_
25	consequences	consequence	NNS	_	23	dobj	23:A1=PPT
26	for	for	IN	_	25	prep	_
27	the	the	DT	_	28	det	_
28	company	company	NN	_	26	pobj	_
29	,	,	,	_	28	punct	_
30	our	our	PRP$	_	31	poss	_
31	employees	employee	NNS	_	28	conj	_
32	and	and	CC	_	31	cc	_
33	the	the	DT	_	37	det	_
34	life	life	NN	_	36	hmod	_
35	-	-	HYPH	_	36	hyph	_
36	sciences	science	NNS	_	37	nn	_
37	sector	sector	NN	_	31	conj	_
38	in	in	IN	_	37	prep	_
39	the	the	DT	_	40	det	_
40	UK	uk	NNP	_	38	pobj	_
41	,	,	,	_	40	punct	_
42	Sweden	sweden	NNP	_	40	conj	_
43	and	and	CC	_	42	cc	_
44	the	the	DT	_	45	det	_
45	US	us	NNP	_	42	conj	_
46	,	,	,	_	48	punct	_
47	"	"	''	_	48	punct	_
48	said	say	VBD	pb=say.01	0	root	_
49	AstraZeneca	astrazeneca	NNP	_	50	nn	_
50	chairman	chairman	NN	_	52	nn	_
51	Leif	leif	NNP	_	52	nn	_
52	Johansson	johansson	NNP	_	48	nsubj	48:A0
53	.	.	.	_	48	punct	_

1	On	on	IN	_	11	prep	11:AM-TMP
2	Friday	friday	NNP	_	1	pobj	_
3	,	,	,	_	11	punct	_
4	Pfizer	pfizer	NNP	_	11	nsubj	7:A0=PAG;11:A0=PAG
5	,	,	,	_	4	punct	_
6	which	which	WDT	_	7	nsubj	7:R-A0
7	makes	make	VBZ	pb=make.02	4	rcmod	_
8	Viagra	viagra	NNP	_	7	dobj	7:A1=PRD
9	,	,	,	_	4	punct	_
10	had	have	VBD	_	11	aux	_
11	lifted	lift	VBN	pb=lift.02	0	root	_
12	its	its	PRP$	_	13	poss	_
13	proposal	proposal	NN	_	11	dobj	11:A1=PPT
14	to	to	TO	p2=IN	15	aux	_
15	£53.50	£0	VB	p2=CD|pb=£0.01	13	infmod	_
16	per	per	IN	p2=FW	15	prep	15:A1
17	share	share	NN	_	16	pobj	_
18	,	,	,	_	11	punct	_
19	from	from	IN	_	11	prep	11:AM-ADV
20	the	the	DT	_	22	det	_
21	previous	previous	JJ	_	22	amod	_
22	level	level	NN	_	19	pobj	_
23	of	of	IN	_	22	prep	_
24	£50	£0	NN	p2=NNS	23	pobj	_
25	.	.	.	_	11	punct	_

1	However	however	RB	_	4	advmod	4:AM-DIS
2	,	,	,	_	4	punct	_
3	AstraZeneca	astrazeneca	NNP	_	4	nsubj	4:A0=PAG
4	declared	declare	VBD	pb=declare.02	0	root	_
5	that	that	IN	_	9	complm	_
6	it	it	PRP	_	9	nsubj	12:A0=PAG;9:A1=PPT
7	would	would	MD	_	9	aux	9:AM-MOD
8	only	only	RB	_	9	advmod	9:AM-ADV
9	be	be	VB	pb=be.01	4	ccomp	4:A1=PPT
10	prepared	prepared	JJ	p2=VBN	9	acomp	9:A2=PRD
11	to	to	TO	_	12	aux	_
12	recommend	recommend	VB	pb=recommend.01	10	xcomp	_
13	an	an	DT	_	14	det	_
14	offer	offer	NN	_	12	dobj	12:A1=PPT
15	of	of	IN	_	14	prep	_
16	more	more	JJR	_	18	amod	_
17	than	than	IN	_	18	quantmod	_
18	10	0	CD	_	19	num	_
19	percent	percent	NN	_	15	pobj	_
20	above	above	IN	_	14	prep	_
21	the	the	DT	_	23	det	_
22	£53.50	£0	NN	p2=CD	23	nn	_
23	level	level	NN	_	20	pobj	_
24	,	,	,	_	9	punct	_
25	indicating	indicate	VBG	pb=indicate.01	9	advcl	_
26	a	a	DT	_	27	det	_
27	price	price	NN	_	25	dobj	25:A1=PPT
28	of	of	IN	_	27	prep	_
29	£58.85	£0	NN	p2=NNP	28	pobj	_
30	or	or	CC	_	27	cc	_
31	£3.85	£0	,	p2=CD	25	punct	_
32	more	more	JJR	p2=RBR	25	conj	_
33	than	than	IN	_	32	prep	_
34	the	the	DT	_	36	det	_
35	latest	late	JJS	_	36	amod	_
36	offer	offer	NN	p2=VBP	33	pobj	_
37	on	on	IN	_	36	prep	_
38	Sunday	sunday	NNP	_	37	pobj	_
39	.	.	.	_	4	punct	_

1	"	"	``	_	27	punct	_
2	The	the	DT	_	4	det	_
3	final	final	JJ	_	4	amod	_
4	proposal	proposal	NN	_	5	nsubj	5:A1=PPT
5	is	be	VBZ	pb=be.01	27	ccomp	27:A1=PPT
6	a	a	DT	_	8	det	_
7	minor	minor	JJ	_	8	amod	_
8	improvement	improvement	NN	_	5	attr	10:A0;12:A1=PPT;24:A1=PPT;5:A2=PRD
9	which	which	WDT	_	10	nsubj	10:R-A0;12:R-A1;24:R-A1
10	continues	continue	VBZ	pb=continue.01	8	rcmod	_
11	to	to	TO	_	12	aux	_
12	fall	fall	VB	pb=fall.01	10	xcomp	10:A1=PPT
13	short	short	RB	p2=JJ	12	advmod	12:A4=GOL
14	of	of	IN	_	13	prep	_
15	the	the	DT	_	16	det	_
16	board	board	NN	_	18	poss	_
17	's	's	POS	_	16	possessive	_
18	view	view	NN	_	14	pobj	_
19	of	of	IN	_	18	prep	_
20	value	value	NN	_	19	pobj	_
21	and	and	CC	_	10	cc	_
22	has	have	VBZ	_	24	aux	_
23	been	be	VBN	_	24	auxpass	_
24	rejected	reject	VBN	pb=reject.01	10	conj	_
25	,	,	,	_	27	punct	_
26	"	"	''	_	27	punct	_
27	said	say	VBD	pb=say.01	0	root	_
28	Johansson	johansson	NNP	_	27	nsubj	27:A0
29	.	.	.	_	27	punct	_

1	He	he	PRP	_	2	nsubj	2:A0=PAG
2	added	add	VBD	pb=add.01	0	root	_
3	:	:	:	_	2	punct	_
4	"	"	``	_	2	punct	_
5	As	as	IN	_	21	prep	_
6	an	an	DT	_	8	det	_
7	independent	independent	JJ	p2=NN	8	amod	_
8	company	company	NN	_	5	pobj	_
9	,	,	,	_	21	punct	_
10	the	the	DT	_	12	det	_
11	entire	entire	JJ	_	12	amod	_
12	value	value	NN	_	21	nsubj	21:A1=PPT
13	of	of	IN	_	12	prep	_
14	AstraZeneca	astrazeneca	NNP	_	19	poss	_
15	's	's	POS	_	14	possessive	_
16	(	(	-LRB-	_	17	punct	_
17	drugs	drug	NNS	_	19	nn	_
18	)	)	-RRB-	_	17	punct	_
19	pipeline	pipeline	NN	_	13	pobj	_
20	will	will	MD	p2=NN	21	aux	21:AM-MOD
21	accrue	accrue	VB	pb=accrue.01	2	advcl	_
22	to	to	IN	_	21	prep	_
23	our	our	PRP$	_	24	poss	_
24	shareholders	shareholder	NNS	_	22	pobj	_
25	.	.	.	_	2	punct	_

1	Under	under	IN	_	12	prep	12:AM-LOC
2	Pfizer	pfizer	NNP	_	5	poss	_
3	's	's	POS	_	2	possessive	_
4	final	final	JJ	_	5	amod	_
5	proposal	proposal	NN	_	1	pobj	_
6	,	,	,	_	12	punct	_
7	this	this	DT	_	8	det	_
8	value	value	NN	_	12	nsubjpass	12:A1=PPT
9	would	would	MD	_	12	aux	12:AM-MOD
10	be	be	VB	_	12	auxpass	_
11	significantly	significantly	RB	_	12	advmod	12:AM-MNR
12	diluted	dilute	VBN	pb=dilute.01	0	root	_
13	.	.	.	_	12	punct	_
14	"	"	''	_	12	punct	_

1	Under	under	IN	_	9	prep	9:AM-LOC
2	the	the	DT	_	4	det	_
3	latest	late	JJS	_	4	amod	_
4	bid	bid	NN	_	1	pobj	_
5	,	,	,	_	9	punct	_
6	Pfizer	pfizer	NNP	p2=NN	7	nn	_
7	shareholders	shareholder	NNS	_	9	nsubj	9:A0=PAG
8	would	would	MD	_	9	aux	9:AM-MOD
9	own	own	VB	p2=RB|pb=own.01	0	root	_
10	approximately	approximately	RB	_	11	advmod	_
11	73	0	CD	_	12	num	_
12	percent	percent	NN	_	9	dobj	9:A1=PPT
13	of	of	IN	_	12	prep	_
14	the	the	DT	_	16	det	_
15	new	new	JJ	_	16	amod	_
16	firm	firm	NN	_	13	pobj	_
17	,	,	,	_	9	punct	_
18	while	while	IN	_	25	mark	_
19	the	the	DT	_	21	det	_
20	British	british	JJ	_	21	amod	_
21	group	group	NN	_	23	poss	_
22	's	's	POS	_	21	possessive	_
23	shareholders	shareholder	NNS	_	25	nsubj	25:A0=PAG
24	would	would	MD	_	25	aux	25:AM-MOD
25	hold	hold	VB	pb=hold.01	9	advcl	9:AM-ADV
26	27	0	CD	_	27	num	_
27	percent	percent	NN	_	25	dobj	25:A1=PPT
28	.	.	.	_	9	punct	_

1	AstraZeneca	astrazeneca	NNP	_	12	nsubj	6:A0=PAG;12:A0=PAG
2	,	,	,	_	1	punct	_
3	which	which	WDT	_	6	nsubj	6:R-A0
4	has	have	VBZ	_	6	aux	_
5	repeatedly	repeatedly	RB	_	6	advmod	6:AM-MNR
6	snubbed	snub	VBN	p2=JJR|pb=snub.01	1	rcmod	_
7	Pfizer	pfizer	NNP	_	10	poss	_
8	's	's	POS	_	7	possessive	_
9	takeover	takeover	NN	_	10	nn	_
10	attempt	attempt	NN	_	6	dobj	6:A1=PPT
11	,	,	,	_	12	punct	_
12	attacked	attack	VBD	pb=attack.01	0	root	_
13	the	the	DT	_	14	det	_
14	bid	bid	NN	_	12	dobj	12:A1=PPT
15	for	for	IN	_	14	prep	_
16	offering	offer	VBG	p2=NN|pb=offer.01	15	pcomp	_
17	to	to	TO	_	18	aux	_
18	establish	establish	VB	pb=establish.01	16	xcomp	16:A1=PPT
19	its	its	PRP$	_	23	poss	_
20	corporate	corporate	JJ	p2=NN	23	amod	_
21	and	and	CC	_	20	cc	_
22	tax	tax	NN	_	20	conj	_
23	residency	residency	NN	_	18	dobj	18:A1=PPT
24	in	in	IN	_	18	prep	18:AM-LOC
25	England	england	NNP	_	24	pobj	_
26	.	.	.	_	12	punct	_

1	Pfizer	pfizer	NNP	p2=NN	2	nsubj	2:A0=PAG;4:A0=PAG
2	wants	want	VBZ	pb=want.01	0	root	_
3	to	to	TO	_	4	aux	_
4	create	create	VB	pb=create.01	2	xcomp	2:A1=PPT
5	a	a	DT	_	8	det	_
6	new	new	JJ	_	8	amod	_
7	pharmaceuticals	pharmaceutical	NNS	_	8	nn	_
8	giant	giant	NN	p2=JJ	4	dobj	4:A1=PPT;12:A1
9	which	which	WDT	_	12	nsubjpass	12:R-A1
10	would	would	MD	_	12	aux	12:AM-MOD
11	be	be	VB	_	12	auxpass	_
12	domiciled	domicile	VBN	pb=domicile.01	8	rcmod	_
13	for	for	IN	_	12	prep	12:A2
14	tax	tax	NN	_	15	nn	_
15	purposes	purpose	NNS	_	13	pobj	_
16	in	in	IN	_	15	prep	_
17	Britain	britain	NNP	_	16	pobj	_
18	.	.	.	_	2	punct	_

1	"	"	``	_	32	punct	_
2	Pfizer	pfizer	NNP	_	4	poss	_
3	's	's	POS	_	2	possessive	_
4	approach	approach	NN	_	10	nsubj	10:A1=PPT;15:A1=PPT
5	throughout	throughout	IN	_	4	prep	_
6	its	its	PRP$	_	7	poss	_
7	pursuit	pursuit	NN	_	5	pobj	_
8	of	of	IN	_	7	prep	_
9	AstraZeneca	astrazeneca	NNP	_	8	pobj	_
10	appears	appear	VBZ	pb=appear.02	32	ccomp	32:A1=PPT
11	to	to	TO	_	15	aux	_
12	have	have	VB	_	15	aux	_
13	been	be	VBN	_	15	auxpass	_
14	fundamentally	fundamentally	RB	_	15	advmod	15:AM-MNR
15	driven	drive	VBN	pb=drive.02	10	xcomp	10:C-A1
16	by	by	IN	_	15	agent	15:A0=PAG
17	the	the	DT	_	20	det	_
18	corporate	corporate	JJ	_	20	amod	_
19	financial	financial	JJ	_	20	amod	_
20	benefits	benefit	NNS	_	16	pobj	_
21	to	to	IN	_	20	prep	_
22	its	its	PRP$	_	23	poss	_
23	shareholders	shareholder	NNS	_	21	pobj	_
24	of	of	IN	_	23	prep	_
25	cost	cost	NN	p2=JJ	26	nn	_
26	savings	saving	NNS	_	24	pobj	_
27	and	and	CC	_	26	cc	_
28	tax	tax	NN	_	29	nn	_
29	minimisation	minimisation	NN	_	26	conj	_
30	,	,	,	_	32	punct	_
31	"	"	''	_	32	punct	_
32	added	add	VBD	p2=VBN|pb=add.01	0	root	_
33	Johansson	johansson	NNP	_	32	nsubj	32:A0=PAG
34	.	.	.	_	32	punct	_

1	This	this	DT	_	2	nsubj	2:A1=PPT;4:A1=PPT
2	appeared	appear	VBD	pb=appear.02	0	root	_
3	to	to	TO	_	4	aux	_
4	be	be	VB	pb=be.01	2	xcomp	2:C-A1
5	a	a	DT	_	6	det	_
6	reference	reference	NN	_	4	attr	4:A2=PRD
7	to	to	IN	_	6	prep	_
8	big	big	JJ	_	10	amod	_
9	tax	tax	NN	_	10	nn	_
10	charges	charge	NNS	_	7	pobj	13:A1=PPT
11	which	which	WDT	_	13	nsubj	13:R-A1
12	would	would	MD	_	13	aux	13:AM-MOD
13	fall	fall	VB	pb=fall.01	10	rcmod	_
14	due	due	JJ	_	13	advmod	13:A4=GOL
15	on	on	IN	_	13	prep	13:AM-ADV
16	profits	profit	NNS	_	15	pobj	17:A1=PPT
17	held	hold	VBN	pb=hold.01	16	partmod	_
18	abroad	abroad	RB	_	17	advmod	17:AM-LOC
19	should	should	MD	_	21	aux	21:AM-MOD
20	Pfizer	pfizer	NNP	_	21	nsubj	21:A0=PAG;23:A0=PAG
21	decide	decide	VB	pb=decide.01	2	advcl	_
22	to	to	TO	_	23	aux	_
23	transfer	transfer	VB	pb=transfer.01	21	xcomp	21:A1=PPT
24	them	them	PRP	_	23	dobj	23:A1=PPT
25	to	to	IN	_	23	prep	23:A2=GOL
26	the	the	DT	_	28	det	_
27	United	united	NNP	_	28	nn	_
28	States	states	NNP	_	25	pobj	_
29	.	.	.	_	2	punct	_

1	"	"	``	p2=''	39	punct	_
2	From	from	IN	_	39	prep	_
3	our	our	PRP$	_	5	poss	_
4	first	#ord#	JJ	_	5	amod	_
5	meeting	meeting	NN	_	2	pobj	_
6	in	in	IN	_	5	prep	_
7	January	january	NNP	_	6	pobj	_
8	to	to	IN	_	2	prep	_
9	our	our	PRP$	_	11	poss	_
10	latest	late	JJS	_	11	amod	_
11	discussion	discussion	NN	_	8	pobj	_
12	yesterday	yesterday	NN	_	2	npadvmod	_
13	,	,	,	_	2	punct	_
14	and	and	CC	_	2	cc	_
15	in	in	IN	_	25	prep	25:AM-LOC
16	the	the	DT	_	19	det	_
17	numerous	numerous	JJ	_	19	amod	_
18	phone	phone	NN	_	19	nn	_
19	calls	call	NNS	p2=VBZ	15	pobj	_
20	in	in	IN	p2=RP	19	prep	_
21	between	between	IN	p2=NN	2	conj	_
22	,	,	,	_	25	punct	_
23	Pfizer	pfizer	NNP	_	25	nsubj	27:A0=PAG;25:A1=PAG
24	has	have	VBZ	_	25	aux	_
25	failed	fail	VBN	pb=fail.01	39	ccomp	39:A1=PPT
26	to	to	TO	_	27	aux	_
27	make	make	VB	pb=make.02	25	xcomp	25:A2=PPT
28	a	a	DT	_	35	det	_
29	compelling	compelling	JJ	_	35	amod	_
30	strategic	strategic	JJ	_	35	amod	_
31	,	,	,	_	30	punct	_
32	business	business	NN	_	35	nn	_
33	or	or	CC	_	32	cc	_
34	value	value	NN	_	32	conj	_
35	case	case	NN	_	27	dobj	27:A1=PRD
36	,	,	,	_	39	punct	_
37	"	"	''	p2=``	39	punct	_
38	Johansson	johansson	NNP	_	39	nsubj	39:A0
39	said	say	VBD	pb=say.01	0	root	_
40	.	.	.	_	39	punct	_

1	"	"	``	_	4	punct	_
2	The	the	DT	_	3	det	_
3	board	board	NN	_	4	nsubj	4:A1=PPT
4	is	be	VBZ	pb=be.01	0	root	_
5	firm	firm	JJ	p2=NN	4	acomp	4:A2=PRD
6	in	in	IN	_	5	prep	_
7	its	its	PRP$	_	8	poss	_
8	conviction	conviction	NN	_	6	pobj	_
9	as	as	IN	p2=RB	8	prep	_
10	to	to	IN	_	9	prep	_
11	the	the	DT	_	13	det	_
12	appropriate	appropriate	JJ	_	13	amod	_
13	terms	term	NNS	_	10	pobj	_
14	to	to	TO	_	15	aux	_
15	recommend	recommend	VB	pb=recommend.01	13	infmod	_
16	to	to	IN	_	15	prep	15:A2=GOL
17	shareholders	shareholder	NNS	_	16	pobj	_
18	.	.	.	_	4	punct	_
19	"	"	''	_	4	punct	_

1	"	"	``	p2=''	4	punct	_
2	AstraZeneca	astrazeneca	NNP	_	4	nsubj	4:A0=PAG
3	has	have	VBZ	_	4	aux	_
4	created	create	VBN	pb=create.01	0	root	_
5	a	a	DT	_	6	det	_
6	culture	culture	NN	_	4	dobj	4:A1=PPT
7	of	of	IN	_	6	prep	_
8	innovation	innovation	NN	_	7	pobj	_
9	,	,	,	_	6	punct	_
10	with	with	IN	_	6	prep	_
11	science	science	NN	_	10	pobj	_
12	at	at	IN	_	4	prep	4:AM-LOC
13	the	the	DT	_	14	det	_
14	heart	heart	NN	_	12	pobj	23:A0;21:A1
15	of	of	IN	_	14	prep	_
16	its	its	PRP$	_	17	poss	_
17	operations	operation	NNS	_	15	pobj	_
18	,	,	,	_	14	punct	_
19	which	which	WDT	_	21	nsubj	23:R-A0;21:R-A1
20	will	will	MD	_	21	aux	21:AM-MOD
21	continue	continue	VB	pb=continue.01	14	rcmod	_
22	to	to	TO	_	23	aux	_
23	create	create	VB	pb=create.01	21	xcomp	21:A1=PPT
24	significant	significant	JJ	_	25	amod	_
25	value	value	NN	_	23	dobj	23:A1=PPT
26	for	for	IN	_	23	prep	23:A3=GOL
27	patients	patient	NNS	_	26	pobj	_
28	,	,	,	_	27	punct	_
29	shareholders	shareholder	NNS	_	27	conj	_
30	and	and	CC	_	29	cc	_
31	all	all	DT	_	32	det	_
32	stakeholders	stakeholder	NNS	_	29	conj	_
33	of	of	IN	_	32	prep	_
34	AstraZeneca	astrazeneca	NNP	_	33	pobj	_
35	.	.	.	_	4	punct	_
36	"	"	''	_	4	punct	_

1	Pfizer	pfizer	NNP	p2=NN	3	nsubj	3:A0=PAG
2	had	have	VBD	_	3	aux	_
3	stated	state	VBN	pb=state.01	0	root	_
4	on	on	IN	_	3	prep	3:AM-TMP
5	Sunday	sunday	NNP	_	4	pobj	_
6	that	that	IN	_	10	complm	_
7	its	its	PRP$	_	9	poss	_
8	latest	late	JJS	_	9	amod	_
9	offer	offer	NN	_	10	nsubj	10:A1=PPT
10	was	be	VBD	pb=be.01	3	ccomp	3:A1=PPT
11	the	the	DT	_	15	det	_
12	fourth	#ord#	JJ	_	15	amod	_
13	and	and	CC	_	12	cc	_
14	final	final	JJ	_	12	conj	_
15	approach	approach	NN	_	10	attr	10:A2=PRD
16	,	,	,	_	10	punct	_
17	adding	add	VBG	pb=add.01	10	advcl	10:AM-ADV
18	that	that	IN	_	22	complm	_
19	it	it	PRP	_	22	nsubj	22:A1=PPT
20	would	would	MD	_	22	aux	22:AM-MOD
21	not	not	RB	_	22	neg	22:AM-NEG
22	go	go	VB	pb=go.08	17	ccomp	17:A1=PPT
23	hostile	hostile	JJ	p2=RB	22	acomp	22:A2=PRD
24	.	.	.	_	3	punct	_

1	The	the	DT	_	3	det	_
2	US	us	NNP	_	3	nn	_
3	group	group	NN	_	4	nsubj	4:A0=PAG
4	added	add	VBD	pb=add.01	0	root	_
5	that	that	IN	_	7	complm	_
6	it	it	PRP	_	7	nsubj	7:A0
7	hoped	hope	VBD	pb=hope.01	4	ccomp	4:A1=PPT
8	the	the	DT	_	11	det	_
9	final	final	JJ	_	11	amod	_
10	takeover	takeover	NN	_	11	nn	_
11	bid	bid	NN	_	13	nsubj	13:A0=PAG
12	would	would	MD	_	13	aux	13:AM-MOD
13	put	put	VB	pb=put.01	7	ccomp	7:A1=PPT
14	pressure	pressure	NN	_	13	dobj	13:A1=PPT
15	on	on	IN	_	13	prep	13:A2=GOL
16	the	the	DT	_	17	det	_
17	company	company	NN	_	19	poss	_
18	's	's	POS	_	17	possessive	_
19	board	board	NN	_	15	pobj	_
20	to	to	TO	_	21	aux	_
21	engage	engage	VB	pb=engage.01	13	advcl	13:AM-PRP
22	with	with	IN	_	21	prep	21:A2=PPT
23	the	the	DT	_	24	det	_
24	offer	offer	NN	_	22	pobj	_
25	.	.	.	_	4	punct	_

1	Johansson	johansson	NNP	_	2	nsubj	2:A0=PAG
2	added	add	VBD	pb=add.01	0	root	_
3	that	that	IN	p2=DT	16	complm	_
4	AstraZeneca	astrazeneca	NNP	_	6	nn	_
5	chief	chief	JJ	p2=NN	6	amod	_
6	executive	executive	NN	_	8	nn	_
7	Pascal	pascal	NNP	_	8	nn	_
8	Soriot	soriot	NNP	p2=JJ	16	nsubj	16:A0=PAG
9	and	and	CC	_	8	cc	_
10	chief	chief	JJ	_	12	amod	_
11	financial	financial	JJ	_	12	amod	_
12	officer	officer	NN	_	14	nn	_
13	Marc	marc	NNP	_	14	nn	_
14	Dunoyer	dunoyer	NNP	_	8	conj	_
15	had	have	VBD	_	16	aux	_
16	held	hold	VBN	pb=hold.04	2	ccomp	2:A1=PPT
17	"	"	``	_	20	punct	_
18	lengthy	lengthy	JJ	_	20	amod	_
19	"	"	''	_	20	punct	_
20	talks	talk	NNS	_	16	dobj	16:A1=PPT
21	with	with	IN	_	20	prep	_
22	Pfizer	pfizer	NNP	p2=NN	21	pobj	_
23	over	over	IN	_	20	prep	_
24	the	the	DT	_	25	det	_
25	weekend	weekend	NN	_	23	pobj	_
26	.	.	.	_	2	punct	_

1	"	"	``	p2=''	3	punct	_
2	Pascal	pascal	NNP	_	3	nn	_
3	Soriot	soriot	NNP	_	9	nsubj	9:A0=PAG
4	,	,	,	_	3	punct	_
5	Marc	marc	NNP	_	6	nn	_
6	Dunoyer	dunoyer	NNP	_	3	conj	_
7	and	and	CC	_	6	cc	_
8	I	I	PRP	_	6	conj	_
9	had	have	VBD	pb=have.03	36	ccomp	36:A1=PPT
10	a	a	DT	_	12	det	_
11	lengthy	lengthy	JJ	_	12	amod	_
12	discussion	discussion	NN	_	9	dobj	9:A1=PPT
13	with	with	IN	_	12	prep	_
14	Pfizer	pfizer	NNP	p2=NN	13	pobj	_
15	over	over	IN	_	12	prep	_
16	the	the	DT	_	17	det	_
17	weekend	weekend	NN	_	15	pobj	_
18	about	about	IN	_	12	prep	_
19	the	the	DT	_	20	det	_
20	proposal	proposal	NN	_	18	pobj	22:AM-PRR
21	Pfizer	pfizer	NNP	p2=NN	22	nsubj	22:A0=PAG
22	made	make	VBD	pb=make.01	20	rcmod	_
23	on	on	IN	_	22	prep	22:AM-TMP
24	Friday	friday	NNP	_	25	nn	_
25	evening	evening	NN	_	23	pobj	_
26	at	at	IN	_	22	prep	22:AM-LOC
27	a	a	DT	_	28	det	_
28	value	value	NN	_	26	pobj	_
29	of	of	IN	_	28	prep	_
30	£53.50	£0	NN	p2=CD	29	pobj	_
31	per	per	IN	_	30	prep	_
32	share	share	NN	_	31	pobj	_
33	,	,	,	_	36	punct	_
34	"	"	''	_	36	punct	_
35	he	he	PRP	_	36	nsubj	36:A0
36	said	say	VBD	pb=say.01	0	root	_
37	.	.	.	_	36	punct	_

1	"	"	``	_	7	punct	_
2	During	during	IN	_	7	prep	7:AM-TMP
3	this	this	DT	_	4	det	_
4	discussion	discussion	NN	_	2	pobj	_
5	,	,	,	_	7	punct	_
6	Pfizer	pfizer	NNP	_	7	nsubj	7:A0
7	said	say	VBD	pb=say.01	0	root	_
8	that	that	IN	_	11	complm	_
9	it	it	PRP	_	11	nsubj	11:A0=PAG
10	could	could	MD	_	11	aux	11:AM-MOD
11	consider	consider	VB	pb=consider.01	7	ccomp	7:A1=PPT
12	only	only	RB	p2=JJ	13	advmod	_
13	minor	minor	JJ	_	14	amod	_
14	improvements	improvement	NNS	_	11	dobj	11:A1
15	in	in	IN	_	14	prep	_
16	the	the	DT	_	18	det	_
17	financial	financial	JJ	_	18	amod	_
18	terms	term	NNS	_	15	pobj	_
19	of	of	IN	_	18	prep	_
20	the	the	DT	_	22	det	_
21	Friday	friday	NNP	_	22	nn	_
22	proposal	proposal	NN	_	19	pobj	_
23	.	.	.	_	7	punct	_
24	"	"	''	_	7	punct	_

1	In	in	IN	_	5	prep	5:AM-ADV
2	response	response	NN	_	1	pobj	_
3	,	,	,	_	5	punct	_
4	we	we	PRP	_	5	nsubj	5:A0=CAU;8:A0=PAG
5	indicated	indicate	VBD	pb=indicate.01	0	root	_
6	,	,	,	_	5	punct	_
7	even	even	RB	_	8	advmod	8:AM-ADV
8	assuming	assume	VBG	pb=assume.02	5	advcl	5:AM-ADV
9	that	that	IN	p2=DT	17	complm	_
10	other	other	JJ	_	12	amod	_
11	key	key	JJ	_	12	amod	_
12	aspects	aspect	NNS	_	17	nsubj	17:A1=PPT
13	of	of	IN	_	12	prep	_
14	any	any	DT	_	15	det	_
15	proposal	proposal	NN	_	13	pobj	_
16	had	have	VBD	_	17	aux	_
17	been	be	VBN	pb=be.01	8	ccomp	8:A1=PPT
18	satisfactory	satisfactory	JJ	_	17	acomp	17:A2=PRD
19	,	,	,	_	17	punct	_
20	that	that	IN	_	37	mark	_
21	the	the	DT	_	22	det	_
22	price	price	NN	_	37	nsubj	39:A1=PPT;30:AM-LOC
23	at	at	IN	_	30	prep	30:R-AM-LOC
24	which	which	WDT	_	23	pobj	_
25	the	the	DT	_	26	det	_
26	board	board	NN	_	30	nsubj	33:A0=PAG;30:A1=PPT
27	of	of	IN	_	26	prep	_
28	AstraZeneca	astrazeneca	NNP	_	27	pobj	_
29	would	would	MD	_	30	aux	30:AM-MOD
30	be	be	VB	pb=be.01	22	rcmod	_
31	prepared	prepared	JJ	p2=VBN	30	acomp	30:A2=PRD
32	to	to	TO	_	33	aux	_
33	provide	provide	VB	pb=provide.01	31	xcomp	_
34	a	a	DT	_	35	det	_
35	recommendation	recommendation	NN	_	33	dobj	33:A1=PPT
36	would	would	MD	_	37	aux	_
37	have	have	VB	pb=have.02	17	conj	_
38	to	to	TO	_	39	aux	_
39	be	be	VB	pb=be.01	37	xcomp	_
40	more	more	JJR	_	42	amod	_
41	than	than	IN	_	42	quantmod	_
42	10	0	CD	_	43	num	_
43	percent	percent	NN	_	39	attr	39:A2=PRD
44	above	above	IN	_	43	prep	_
45	the	the	DT	_	46	det	_
46	level	level	NN	_	44	pobj	47:A1
47	contained	contain	VBN	p2=VBD|pb=contain.01	46	partmod	_
48	in	in	IN	_	47	prep	47:A0
49	Pfizer	pfizer	NNP	_	52	poss	_
50	's	's	POS	_	49	possessive	_
51	Friday	friday	NNP	_	52	nn	_
52	proposal	proposal	NN	_	48	pobj	_
53	.	.	.	_	5	punct	_

1	"	"	``	p2=''	6	punct	_
2	Politicians	politician	NNS	_	6	nsubj	6:A0=PAG
3	and	and	CC	_	2	cc	_
4	unions	union	NNS	_	2	conj	_
5	have	have	VBP	_	6	aux	_
6	expressed	express	VBN	p2=VBD|pb=express.01	0	root	_
7	concern	concern	NN	_	6	dobj	6:A1=PPT
8	that	that	IN	_	14	complm	_
9	a	a	DT	_	12	det	_
10	tie	tie	NN	_	12	hmod	_
11	-	-	HYPH	_	12	hyph	_
12	up	up	NN	_	14	nsubj	14:A0=PAG
13	would	would	MD	_	14	aux	14:AM-MOD;19:AM-MOD
14	lead	lead	VB	pb=lead.03	7	ccomp	_
15	to	to	IN	_	14	prep	14:A2=PRD
16	job	job	NN	_	17	nn	_
17	cuts	cut	NNS	_	15	pobj	_
18	and	and	CC	_	14	cc	_
19	damage	damage	VB	pb=damage.01	14	conj	_
20	Britain	britain	NNP	_	22	poss	_
21	's	's	POS	_	20	possessive	_
22	position	position	NN	_	19	dobj	19:A1=PPT
23	as	as	IN	_	22	prep	_
24	a	a	DT	_	28	det	_
25	research	research	NN	_	28	nn	_
26	and	and	CC	_	25	cc	_
27	development	development	NN	_	25	conj	_
28	hub	hub	NN	_	23	pobj	_
29	.	.	.	_	6	punct	_

1	British	british	JJ	_	3	amod	_
2	Prime	prime	NNP	_	3	nn	_
3	Minister	minister	NNP	_	5	nn	_
4	David	david	NNP	_	5	nn	_
5	Cameron	cameron	NNP	_	7	nsubj	7:A0=PAG
6	recently	recently	RB	_	7	advmod	7:AM-TMP
7	called	call	VBD	pb=call.05	0	root	_
8	on	on	IN	_	7	prep	7:C-V
9	Pfizer	pfizer	NNP	_	8	pobj	_
10	to	to	TO	_	11	aux	_
11	give	give	VB	pb=give.01	7	xcomp	7:A1=PPT
12	more	more	JJR	_	13	amod	_
13	assurances	assurance	NNS	_	11	dobj	11:A1=PPT
14	that	that	IN	_	18	mark	_
15	its	its	PRP$	_	17	poss	_
16	takeover	takeover	NN	_	17	nn	_
17	bid	bid	NN	_	18	nsubj	18:A1=PPT
18	is	be	VBZ	pb=be.01	13	ccomp	_
19	in	in	IN	_	18	prep	18:A2=PRD
20	Britain	britain	NNP	_	23	poss	_
21	's	's	POS	_	20	possessive	_
22	national	national	JJ	_	23	amod	_
23	interest	interest	NN	_	19	pobj	_
24	.	.	.	_	7	punct	_

